AJP - Lung Cellular and Molecular Physiology, Vol 273, Issue 5 941-L949, Copyright © 1997 by American Physiological Society

ARTICLES

Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth

B. Driscoll, L. Wu, S. Buckley, F. L. Hall, K. D. Anderson and D. Warburton
Deparment of Surgery, Childrens Hospital Los Angeles Research Institute, University of Southern California School of Medicine 90027, USA.

To investigate the role of cyclin D1 in the regulation of lung cancer cell growth, we created five stably transfected cell lines carrying a cyclin D1 antisense construct. The transfected cells exhibited a marked decrease in the rate of cell growth, in contrast to the original lines (A549 and NCI-H441). The expression of several cell cycle-regulating proteins, including cyclin A, the cyclin-dependent kinases (cdk) 2 and cdk4, in addition to cyclin D1 itself, was markedly decreased. The expression of one cdk inhibitor, p21WAF1/CIP1, increased in the A549-derived cell lines. A specific target of cyclin D1 activity, the growth-suppressing product of the retinoblastoma gene, pRb, exhibited decreased expression and a decreased level of phosphorylation in the transfected cells. Decreased expression of pRb due to a significant increase in its turnover rate suggested that the stability of the protein may depend on phosphorylation by cyclin D1-dependent cdk activity. In addition to the impact on pRb stability, decreased expression of cyclin D1 induced susceptibility to cell death after withdrawal of exogenous growth factors in the antisense transfected cell lines, a response that was not observed in the original cancer cell lines. We conclude that abrogation of cyclin D1 overexpression in lung cancer cells disrupts several key pathways that are required for uncontrolled cell growth and induces those that lead to cell death after growth factor deprivation. Therefore, we speculate that use of antisense cyclin D1 expression in appropriate gene vectors could be a useful method for retarding lung cancer cell growth in accessible tumors such as those of the lung epithelium.

This article has been cited by other articles:

				R. H. Hastings, P. R. Montgrain, R. Quintana, Y. Rascon, L. J. Deftos, and E. Healy Cell cycle actions of parathyroid hormone-related protein in non-small cell lung carcinoma Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L578 - L585. [Abstract] [Full Text] [PDF]

				A. Ryo, Y.-C. Liou, K. P. Lu, and G. Wulf Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer J. Cell Sci., March 1, 2003; 116(5): 773 - 783. [Abstract] [Full Text] [PDF]

				A. Ryo, Y.-C. Liou, G. Wulf, M. Nakamura, S. W. Lee, and K. P. Lu PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells Mol. Cell. Biol., August 1, 2002; 22(15): 5281 - 5295. [Abstract] [Full Text] [PDF]

				A. M. Senderowicz and E. A. Sausville Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators J Natl Cancer Inst, March 1, 2000; 92(5): 376 - 387. [Abstract] [Full Text] [PDF]

				E. R. Sauter, M. Herlyn, S.-C. Liu, S. Litwin, and J. A. Ridge Prolonged Response to Antisense Cyclin D1 in a Human Squamous Cancer Xenograft Model Clin. Cancer Res., February 1, 2000; 6(2): 654 - 660. [Abstract] [Full Text]

				K. M. Fong, Y. Sekido, and J. D. Minna MOLECULAR PATHOGENESIS OF LUNG CANCER J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1136 - 1152. [Abstract] [Full Text] [PDF]

				E. R. Sauter, M. Nesbit, S. Litwin, A. J. P. Klein-Szanto, S. Cheffetz, and M. Herlyn Antisense Cyclin D1 Induces Apoptosis and Tumor Shrinkage in Human Squamous Carcinomas Cancer Res., October 1, 1999; 59(19): 4876 - 4881. [Abstract] [Full Text] [PDF]

				B. Driscoll, S. Buckley, L. Barsky, K. Weinberg, K. D. Anderson, and D. Warburton Abrogation of cyclin D1 expression predisposes lung cancer cells to serum deprivation-induced apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L679 - L687. [Abstract] [Full Text] [PDF]